AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand
· Delayed Price · Currency is NZD 3.750
0.00 (0.00%)
Dec 5, 2025, 4:42 PM NZST
AFT Pharmaceuticals Revenue
AFT Pharmaceuticals had revenue of 114.94M NZD in the half year ending September 30, 2025, with 37.47% growth. This brings the company's revenue in the last twelve months to 236.25M, up 19.01% year-over-year. In the fiscal year ending March 31, 2025, AFT Pharmaceuticals had annual revenue of 208.02M with 6.45% growth.
Revenue (ttm)
236.25M
Revenue Growth
+19.01%
P/S Ratio
1.66
Revenue / Employee
1.99M
Employees
119
Market Cap
393.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 208.02M | 12.61M | 6.45% |
| Mar 31, 2024 | 195.41M | 38.77M | 24.75% |
| Mar 31, 2023 | 156.64M | 26.33M | 20.20% |
| Mar 31, 2022 | 130.31M | 17.21M | 15.22% |
| Mar 31, 2021 | 113.11M | 7.51M | 7.11% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fisher & Paykel Healthcare Corporation | 2.16B |
| EBOS Group | 13.24B |
| Summerset Group Holdings | 340.08M |
| Ryman Healthcare | 807.48M |
| Oceania Healthcare | 259.60M |
| Green Cross Health | 528.32M |
| Pacific Edge | 18.24M |
| Radius Residential Care | 192.26M |
AFT Pharmaceuticals News
- 15 days ago - AFT Pharmaceuticals Ltd (ASX:AFP) Half Year 2026 Earnings Call Highlights: Strong Sales Growth ... - GuruFocus
- 15 days ago - Half Year 2026 AFT Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus